Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome

oleh: Xiaoman Du, MD, Yudi Chen, MD, Jianmin Chang, MD, Xuelin Sun, MD, PhD, Yue Zhang, MS, Meng Zhang, BM, Marcus Maurer, MD, PhD, Yanming Li, MD, Zuotao Zhao, MD, PhD, Xunliang Tong, MD, PhD

Format: Article
Diterbitkan: Elsevier 2022-11-01

Deskripsi

Subjek

eosinophils; pulmonary; skin; therapy; type 2 inflammation